K

Kazia Therapeutics Limited
D

KZIA

5.43000
USD
-0.07
(-1.27%)
Market Closed
Volume
376
EPS
-13
Div Yield
-
P/E
-1
Market Cap
23,647,460
OverviewSignalsIdeasNews
Related Instruments
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    B
    BNTC
    0.130
    (1.25%)
    10.500 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    G
    GHSI
    0
    (0%)
    0.000000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    More
News

Title: Kazia Therapeutics Limited

Sector: Healthcare
Industry: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.